01 February 2022
A leading Midlands generic medicines manufacturer and supplier has become a patron of Greater Birmingham Chambers of Commerce.
Morningside Pharmaceuticals has a mission to ‘make quality healthcare an affordable and accessible reality throughout the world’, and has become a Chamber patron to encourage East and West Midlands’ businesses collaborations.
The company, based in Loughborough, is an award winning manufacturer, wholesaler and exporter of branded and generic medicines and healthcare products to the UK and international markets.
Since inception in the early 1990s, Morningside has exported to more than 120 countries globally and has over 240 generic and branded licensed medicines in the UK and EU.
In the UK, the company’s licensed medicines are distributed twice daily to NHS hospitals and pharmacies.
Globally, Morningside is one of the UK’s leading suppliers of a wide-range of medicines to global aid agencies, charities and NGOs, including Unicef, The World Health Organisation (WHO), Red Cross and MSF.
Morningside is also expanding into new international markets, where product registrations in individual countries offer an opportunity to grow into the public and private sectors.
The business was founded over 30 years ago by Dr Nik Kotecha OBE, who is now the company’s chairman.
He is also a Department for International Trade Export Champion, Centre for Social Justice (CSJ) Board Member, Midlands Engine Health & Council Board Member, a CBI Regional Councillor and a Board Member for the British Generics Manufacturers Association (BGMA).
Dr Kotecha (pictured) said: “I am immensely proud to be based in the Midlands, which is the manufacturing heart of the country, as well as having many thriving sectors, including health, life sciences and med tech.
“It’s very important that the Midlands is able to develop a single, unified and powerful voice nationally, to ensure central government provides investment in infrastructure and levelling up support for the diverse range of businesses and communities based here.
“I’m very keen to build collaborations between the public and private sectors, as well as academia, which is why joining the Greater Birmingham Chamber was a great choice for Morningside Pharmaceuticals.
“I am very much looking forward to meeting with other members who share a vision for a strong, more unified and a bright sustainable future for the Midlands.”
Henrietta Brealey, the GBCC’s chief executive, said: “We are delighted to welcome Morningside to our GBCC patrons network.
“Our patrons share our Chamber values and mission to Connect, Support and Grow local businesses. Our relationship with each patron is bespoke and reflects their unique priorities.
“I am looking forward to helping tell both Morningside and Dr Nik’s stories and raise awareness of this phenomenal success and their leading work in innovation, international trade and beyond.
“I also look forward to working with Dr Nik on driving collaboration on Midlands wide voice and representation for businesses, something that is more critical than ever in these fast-changing times.”
Find out more information on Morningside Pharmaceuticals.